Cytori Therapeutics begins US cell therapy failure trial pharmabiz.com San Diego Monday, October 15, 2012, 12:00 Hrs [IST]. Cytori Therapeutics has initiated ATHENA clinical trial to investigate its cell therapy in patients who suffer from a severe form of refractory (untreatable) heart failure due to chronic myocardial ... |
